1. Home
  2. LEXX vs QCLS Comparison

LEXX vs QCLS Comparison

Compare LEXX & QCLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

BUY

Current Price

$2.86

Market Cap

6.7M

Sector

Health Care

ML Signal

BUY

Logo Q/C Technologies Inc.

QCLS

Q/C Technologies Inc.

HOLD

Current Price

$0.56

Market Cap

7.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEXX
QCLS
Founded
2004
2014
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.7M
7.1M
IPO Year
2011
2013

Fundamental Metrics

Financial Performance
Metric
LEXX
QCLS
Price
$2.86
$0.56
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
72.9K
★ 5.8M
Earning Date
11-27-2026
11-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 22.33
EPS
★ N/A
N/A
Revenue
$705,923.00
★ $3,929,527.00
Revenue This Year
N/A
N/A
Revenue Next Year
$6,915.00
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 52.05
32.71
52 Week Low
$0.35
$0.42
52 Week High
$21.60
$11.80

Technical Indicators

Market Signals
Indicator
LEXX
QCLS
Relative Strength Index (RSI) 35.35 26.85
Support Level $2.79 $0.42
Resistance Level $12.98 $1.18
Average True Range (ATR) 0.42 0.10
MACD 0.20 0.04
Stochastic Oscillator 11.57 2.34

Price Performance

Historical Comparison
LEXX
QCLS

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

About QCLS Q/C Technologies Inc.

Q/C Technologies Inc is engaged in building blockchain and cryptocurrency infrastructure that is faster and more energy-efficient through quantum-class laser-based computing. The company uses laser-based processors inspired by quantum technology that can solve complex problems. By combining photonic computing with cryptocurrency systems, the company creates powerful and sustainable solutions for the next generation of blockchain applications.

Share on Social Networks: